Mori M - Search Results

1

ATP11A is a novel predictive marker for metachronous metastasis of colorectal cancer.

Miyoshi N, Ishii H, Mimori K, Tanaka F, Nagai K, Uemura M, Sekimoto M, Doki Y, Mori M. Miyoshi N, et al. Among authors: mori m. Oncol Rep. 2010 Feb;23(2):505-10. Oncol Rep. 2010. PMID: 20043114

2

Prediction of 5'-deoxy-5-fluorouridine sensitivity in colorectal cancer cases by thymidine phosphorylase activity and preliminary identification of susceptibility related genes.

Mimori K, Ueo H, Kuroki T, Shiraishi T, Creer S, Taylor S, Ishii H, Mori M. Mimori K, et al. Among authors: mori m. Oncol Rep. 2004 Jul;12(1):19-23. Oncol Rep. 2004. PMID: 15201953

3

Clinical significance of the loss of MATS1 mRNA expression in colorectal cancer.

Kosaka Y, Mimori K, Tanaka F, Inoue H, Watanabe M, Mori M. Kosaka Y, et al. Among authors: mori m. Int J Oncol. 2007 Aug;31(2):333-8. Int J Oncol. 2007. PMID: 17611689

4

Clinical significance of growth differentiation factor 11 in colorectal cancer.

Yokoe T, Ohmachi T, Inoue H, Mimori K, Tanaka F, Kusunoki M, Mori M. Yokoe T, et al. Among authors: mori m. Int J Oncol. 2007 Nov;31(5):1097-101. Int J Oncol. 2007. PMID: 17912435

5

PDGF-BB is a novel prognostic factor in colorectal cancer.

Nakamura Y, Tanaka F, Yoshikawa Y, Mimori K, Inoue H, Yanaga K, Mori M. Nakamura Y, et al. Among authors: mori m. Ann Surg Oncol. 2008 Aug;15(8):2129-36. doi: 10.1245/s10434-008-9943-9. Epub 2008 May 14. Ann Surg Oncol. 2008. PMID: 18478301

6

Clinical significance of ApoE expression in human gastric cancer.

Sakashita K, Tanaka F, Zhang X, Mimori K, Kamohara Y, Inoue H, Sawada T, Hirakawa K, Mori M. Sakashita K, et al. Among authors: mori m. Oncol Rep. 2008 Dec;20(6):1313-9. Oncol Rep. 2008. PMID: 19020708

7

Over- and under-expressed microRNAs in human colorectal cancer.

Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, Sugihara K, Mori M. Motoyama K, et al. Among authors: mori m. Int J Oncol. 2009 Apr;34(4):1069-75. doi: 10.3892/ijo_00000233. Int J Oncol. 2009. PMID: 19287964

8

RGS16 is a marker for prognosis in colorectal cancer.

Miyoshi N, Ishii H, Sekimoto M, Doki Y, Mori M. Miyoshi N, et al. Among authors: mori m. Ann Surg Oncol. 2009 Dec;16(12):3507-14. doi: 10.1245/s10434-009-0690-3. Epub 2009 Sep 4. Ann Surg Oncol. 2009. PMID: 19760045

9

Notch pathway as candidate therapeutic target in Her2/Neu/ErbB2 receptor-negative breast tumors.

Hirose H, Ishii H, Mimori K, Ohta D, Ohkuma M, Tsujii H, Saito T, Sekimoto M, Doki Y, Mori M. Hirose H, et al. Among authors: mori m. Oncol Rep. 2010 Jan;23(1):35-43. Oncol Rep. 2010. PMID: 19956862

10

TGM2 is a novel marker for prognosis and therapeutic target in colorectal cancer.

Miyoshi N, Ishii H, Mimori K, Tanaka F, Hitora T, Tei M, Sekimoto M, Doki Y, Mori M. Miyoshi N, et al. Among authors: mori m. Ann Surg Oncol. 2010 Apr;17(4):967-72. doi: 10.1245/s10434-009-0865-y. Epub 2009 Dec 22. Ann Surg Oncol. 2010. PMID: 20033322

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,992 results

Search Page

Filters